According to AbCellera 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 30.5671. At the end of 2023 the company had a P/S ratio of 43.6.
Year | P/S ratio | Change |
---|---|---|
2023 | 43.6 | 629.8% |
2022 | 5.97 | -44.36% |
2021 | 10.7 | -76.9% |
2020 | 46.5 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |